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Question
A 25-year-old Spanish male travelled to Senegal in September
2009, where he swam near the Dindefelo fresh-water falls. Five
weeks later, he presented with fever, myalgia, and dry cough. His
complete blood count showed a hemoglobin level of 157 g/L,
platelet count of 123.000 platelets/mL, and a leukocyte count of
8.670 cells/mL, with 9% eosinophils. Malaria smear, blood
cultures, and serologies for common viral and bacterial infections
were negative. Titers of an indirect hemagglutination test for
Schistosoma mansoni were 1:80. The patient was treated with a single
dose of praziquantel (40 mg/kg) and prednisone (30 mg) for three
days. After treatment, the dry cough increased and he developed
moderate dyspnea, with increasing malaise and myalgia. A second
blood sample revealed eosinophilia of 1.200 cells/mL. A chest X-
ray showed patchy infiltrates in both lungs (Figure 1), and a CT
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Figure 1. Chest X-ray showing patchy infiltrates in both lungs.
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scan showed multiple peripheral bilateral pseudonodular lesions
with surrounding ground-glass-opacity halo (Figure 2).
The patient gave consent to have his case details published.
Diagnosis
Acute pulmonary schistosomiasis
The patient was treated with prednisone (1 mg/kg/day) for
seven days and became asymptomatic within 48 hours. A repeat
chest X-ray 24 hours later showed no abnormalities.
He was treated again with praziquantel (40 mg/kg/day) for
three days, three months after initial diagnosis. Antibodies against
Schistosoma species increased in a control blood sample six months
later (titers 1:160). No Schistosoma eggs were found in the four
samples of stools and urine tested.
The patient remained asymptomatic up to 24 months after
treatment.
Discussion
Infection with Schistosoma species is acquired by exposure to
fresh water that contains cercariae, the infective form of this
trematode [1]. The infection is highly endemic in sub-Saharan
Africa, and causes chronic disease with urogenital, intestinal, or
hepatic manifestation in most cases [2,3].
Acute schistosomiasis or Katayama syndrome is an early
manifestation of the infection and may occur between two and
12 weeks after primary infection. It is considered to be a toxemic
syndrome due to a hypersensitivity reaction to the migrating and
maturing larvae of the parasite and its eggs [4,5]. It can be seen in
nonimmune individuals exposed to an infected source of fresh
water. Therefore, acute schistosomiasis is rarely diagnosed in
endemic areas, but frequently observed after infection of naive
travelers to endemic countries, and after infection of naive
populations where the disease is emerging (e.g., due to industri-
alization and construction of dams) [4].
Figure 2. Multiple peripheral bilateral pseudonodular lesions with surrounding ground-glass-opacity halo in CT thorax scan.
doi:10.1371/journal.pntd.0002201.g002
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Symptoms of acute schistosomiasis usually involve fever,
malaise, and high-grade eosinophilia (usually over 3,000 eosino-
phils 109/L) [4,5]. Although eosinophilia has been considered a
constant finding, it is only observed in about 70–80% of cases [6].
Thus, the absence of eosinophilia does not exclude Katayama
syndrome. Other possible symptoms are diarrhoea, urticaria,
edema, hepatosplenomegaly, and cough. Usually the disease is
self-limited, although some patients suffer severe manifestations
and may need hospitalization [1,4,5].
Although not frequently described, pulmonary involvement
with Schistosoma can occur in acute cases and may be much more
common than previously suspected [7,8]. Dry cough is a frequent
symptom in patients with Katayama syndrome, but shortness of
breath, dyspnea, wheeze, and chest pain may also appear [3,7,9].
Chest radiographs may reveal nodular lesions with ill-defined
borders and less frequently pleural effusion or reticulonodular
infiltrates [7,9]. The most common findings when performing a
chest CT scan are pulmonary nodules from 2 to 15 mm, and
ground-glass attenuation areas, as found in our case. The
histopathological translation of these radiological images may be
an interstitial eosinophilic pneumonitis and immune complex
deposition of the lung parenchyma [10,11].
Diagnosis of acute schistosomiasis in travelers remains chal-
lenging, and is often done in retrospect after seroconversion, since
in most cases serological tests and stool examination first become
positive several weeks after exposure [5].
Praziquantel is the drug of choice to treat all the species of
Schistosoma [2]. However, its use is not necessarily effective in the
acute phase of the infection since it has less impact on the
immature worms [5]. In addition, clinical worsening of patients
has been described after treatment, possibly due to an allergic
response to the parasite killing, especially when no steroids are
given concomitantly [5]. These side effects may occur and are
not a reason to refuse treatment. The respiratory symptoms of
our patient worsened after treatment with praziquantel and
steroids: this could be a treatment effect but may also be
provoked by a paradoxical reaction that is described in patients
with Katayama syndrome, even in the absence of any treatment
[5]. Since acute schistosomiasis is considered to be a hypersen-
sitivity reaction, treatment with corticosteroids should be taken
into account, especially in cases with severe manifestations
[5,12].
The use of praziquantel in this acute phase does not preclude
from repeating the treatment two to three months after the acute
phase when all parasites have matured and are susceptible to
praziquantel [2,4].
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Key Learning Points
N Timely diagnosis of acute schistosomiasis still relies on
clinical and epidemiological exposure history.
N Even though dry cough is commonly found in cases of
acute schistosomiasis, severe respiratory complications
might also occur.
N Nodular lesions with ill-defined borders in chest X-ray
and pulmonary nodules with ground-glass attenuation
areas in CT scan are the most common radiological
manifestations of acute pulmonary schistosomiasis.
N Optimal treatment of acute schistosomiasis is still
unclear.
N Symptoms might worsen after treatment with prazi-
quantel. The concomitant use of steroids is highly
recommended.
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